Skip to content
value.today

Intelycare, Inc.

Total raised
$139 M
3 rounds on record
Latest round
$97 M
Mar 2022
First round on record
Sep 2018
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Intelycare, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2022$97 MNo. 3$50 to $250 million

Intelycare, Inc.: Raise no. 3, Mar 2022

Investors in this round

19 investors had bought by the notice of Apr 12, 2022: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for Intelycare, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$97 M of $115 M offered; $18 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
$2,700,000
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Coppins · Executive Officer, Director
  • Ike Nnah · Executive Officer, Director
  • Aashima Gupta · Director
  • Bernard Vogel · Director
  • Janelle Sallenave · Director
  • Keith Figlioli · Director
  • Scott Halsted · Director
  • Tim Adams · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • William Blair (CRD 1252) · Chicago, IllinoisSold in all US states

Signed by David Coppins, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 12, 2022. Read the notice at the SEC.

equitySEC
Feb 2020$31 MNo. 2$10 to $50 million

Intelycare, Inc.: Raise no. 2, Feb 2020

Investors in this round

39 investors had bought by the notice of Feb 28, 2020: 39 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for Intelycare, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$31 M of $31 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Coppins · Executive Officer, Director
  • Ike Nnah · Executive Officer, Director
  • Bernard Vogel · Director
  • Keith Figlioli · Director
  • Scott Halsted · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David Coppins, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 28, 2020. Read the notice at the SEC.

equity, optionsSEC
Sep 2018$11 MNo. 1$10 to $50 million

Intelycare, Inc.: Raise no. 1, Sep 2018

Investors in this round

44 investors had bought by the notice of Nov 1, 2018: 44 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for Intelycare, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$11 M of $11 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Coppins · Executive Officer, Director
  • Ike Nnah · Director
  • Keith Figliolo · Director
  • Scott Halsted · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David Coppins, Chief Executive Officer. Source: SEC Form D, newest notice filed Nov 1, 2018. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Intelycare, Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2022).

    SEC Form D · Apr 2022

  • The industry group it chose in its notices: Other.

    SEC Form D · Apr 2022

That is all the official record says: Intelycare, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

2 named in official filings. Open an investor to see everything it has backed.

Investors in Intelycare, Inc.
InvestorKindAmountRoundRoleSource
Janus Henderson Triton FundFund or asset manager$1 Mheldnot statedHolds shares (fund report, Jun 2026)SEC Form N-PORT
Janus Henderson Venture FundFund or asset manager$0 Mheldnot statedHolds shares (fund report, Jun 2026)SEC Form N-PORT

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 44 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Intelycare, Inc.
NameRoleNamed in
David CoppinsExecutive officerApr 2022
Ike NnahExecutive officerApr 2022
Aashima GuptaDirectorApr 2022
Bernard VogelDirectorApr 2022
David CoppinsDirectorApr 2022
Ike NnahDirectorApr 2022
Janelle SallenaveDirectorApr 2022
Keith FiglioliDirectorApr 2022
Scott HalstedDirectorApr 2022
Tim AdamsDirectorApr 2022
Keith FiglioloDirectorNov 2018